Clinical Trial Results: R1507

Product Name: R1507
Date of Report: To be Published
Phase: I
A Mulitple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

Product Name: R1507
Date of Report: To be Published
Phase: I
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.

Product Name: R1507
Date of Report: To be Published
Phase: II
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Product Name: R1507
Date of Report: To be Published
Phase: II
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Product Name: R1507
Date of Report: To be Published
Phase: II
A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer

Product Name: R1507
Date of Report: To be Published
Phase: I
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

Product Name: R1507
Date of Report: To be Published
Phase: I
A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Product Name: R1507
Date of Report: To be Published
Phase: I
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors